FBXO30 Antibody
-
货号:CSB-PA844709LA01HU
-
规格:¥440
-
促销:
-
图片:
-
Western blot
All lanes: FBXO30 antibody at 10µg/ml + Mouse brain tissue
Secondary
Goat polyclonal to rabbit IgG at 1/10000 dilution
Predicted band size: 83 kDa
Observed band size: 83 kDa -
Immunohistochemistry of paraffin-embedded human skeletal muscle tissue using CSB-PA844709LA01HU at dilution of 1:100
-
-
其他:
产品详情
-
产品名称:Rabbit anti-Homo sapiens (Human) FBXO30 Polyclonal antibody
-
Uniprot No.:Q8TB52
-
基因名:FBXO30
-
别名:FBXO30 antibody; FBX30F-box only protein 30 antibody
-
宿主:Rabbit
-
反应种属:Human, Mouse
-
免疫原:Recombinant Human F-box only protein 30 protein (201-500AA)
-
免疫原种属:Homo sapiens (Human)
-
标记方式:Non-conjugated
本页面中的产品,FBXO30 Antibody (CSB-PA844709LA01HU),的标记方式是Non-conjugated。对于FBXO30 Antibody,我们还提供其他标记。见下表:
-
克隆类型:Polyclonal
-
抗体亚型:IgG
-
纯化方式:>95%, Protein G purified
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
产品提供形式:Liquid
-
应用范围:ELISA, WB, IHC
-
推荐稀释比:
Application Recommended Dilution WB 1:500-1:2000 IHC 1:20-1:200 -
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
相关产品
靶点详情
-
功能:Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Required for muscle atrophy following denervation.
-
基因功能参考文献:
- Results suggest that D6S1581 is highly associated with nasopharyngeal carcinoma, and there may be one or more NPC associated genes near D6S1581, including FBXO30. PMID: 12903040
-
数据库链接:
HGNC: 15600
OMIM: 609101
KEGG: hsa:84085
STRING: 9606.ENSP00000237281
UniGene: Hs.421095
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IF, FC
Species Reactivity: Human, Mouse, Rat
-
-
-
-
-
-